Terms: = Colorectal cancer AND EIF3E, eIF3-p46, 3646, ENSG00000104408, EIF3S6, eIF3e, EIF3-P48, INT6 AND Treatment
5 results:
1. Comprehensive genetic characterization of rectal cancer in a large cohort of Japanese patients: differences according to tumor location.
Hino H; Shiomi A; Hatakeyama K; Kagawa H; Manabe S; Yamaoka Y; Nagashima T; Ohshima K; Urakami K; Akiyama Y; Yamaguchi K
J Gastroenterol; 2022 Jul; 57(7):476-485. PubMed ID: 35449312
[TBL] [Abstract] [Full Text] [Related]
2. R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine.
Han T; Schatoff EM; Murphy C; Zafra MP; Wilkinson JE; Elemento O; Dow LE
Nat Commun; 2017 Jul; 8():15945. PubMed ID: 28695896
[TBL] [Abstract] [Full Text] [Related]
3. Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol.
Kuijpers AM; Mirck B; Aalbers AG; Nienhuijs SW; de Hingh IH; Wiezer MJ; van Ramshorst B; van Ginkel RJ; Havenga K; Bremers AJ; de Wilt JH; Te Velde EA; Verwaal VJ
Ann Surg Oncol; 2013 Dec; 20(13):4224-30. PubMed ID: 23897008
[TBL] [Abstract] [Full Text] [Related]
4. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.
Stang A; Fischbach R; Teichmann W; Bokemeyer C; Braumann D
Eur J Cancer; 2009 Jul; 45(10):1748-56. PubMed ID: 19356924
[TBL] [Abstract] [Full Text] [Related]
5. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D
Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197
[TBL] [Abstract] [Full Text] [Related]
